Previously, in lung cancer or other tumors, it has been found that MPRIP can interact with neurotrophic tyrosine receptor kinase 1 (NTRK1), platelet-derived growth factor receptorβ (PDGFRB), and proto-oncogene such as RAF1 [98,99,100]. The gene discussed is NTRK1; the disease is lung cancer.